Evidence map›Paper›PMID 21535316›Full record

ArticleCancer science2011

MRG-binding protein contributes to colorectal cancer development.

Kiyoshi Yamaguchi, Michihiro Sakai, JooHun Kim, Shin-ichiro Tsunesumi, Tomoaki Fujii, Tsuneo Ikenoue, Yoshinao Yamada, Yoshiyuki Akiyama, Yasuhiko Muto, Rui Yamaguchi and 3 more

Open access · greenAbstract read
In one paragraph

Article in Cancer science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Kiyoshi YamaguchiDivision of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Michihiro Sakai
JooHun Kim
Shin-ichiro Tsunesumi
Tomoaki Fujii
Tsuneo Ikenoue
Yoshinao Yamada
Yoshiyuki Akiyama
Yasuhiko Muto
Rui Yamaguchi
Satoru Miyano
Yusuke Nakamura
Yoichi Furukawa
Advanced Medical Research Institute · USThe University of Tokyo · JPHitachi General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MRGBP (MORF4-related gene-binding protein; also known as chromosome 20 open reading frame 20) encodes a subunit of the transformation/transcription domain-associated protein (TRRAP)/tat-interacting protein 60 (TIP60)-containing histone acetyltransferase complex. We previously showed that MRGBP was upregulated in the majority of colorectal tumors, and the enhanced expression was associated with cell proliferation. In this study, we investigated its role in colorectal carcinogenesis and searched for genes regulated by MRGBP. Immunohistochemical staining of 22 adenomas and 47 carcinomas in the colon and rectum showed that high levels of MRGBP expression were observed more frequently in carcinomas (45%) than adenomas (5%), linking its role to malignant properties of colorectal tumors. No clinicopathological factors were associated with the levels MRGBP expression in colorectal cancer. Copy number analysis revealed that gene amplification is involved in the elevated expression. A genome-wide expression analysis identified a total of 41 genes upregulated by MRGBP. These genes were implicated in biological processes, including DNA replication, minichromosome maintenance, and cell division. Theses results suggest that MRGBP contributes to colorectal carcinogenesis through rendering advantages in cell proliferation and/or division of cancer cells. Our findings might be helpful for the identification of a specific biomarker for colorectal cancer and the development of diagnostic and/or therapeutic approaches.

Indexed as

AgedAged, 80 and overCarrier ProteinsCell Line, TumorColorectal NeoplasmsFemaleGene AmplificationGene Expression ProfilingHistone AcetyltransferasesHumansMaleMiddle AgedNuclear ProteinsRNA, Small InterferingCarrier ProteinsHistone AcetyltransferasesMRGBP protein, humanNuclear ProteinsRNA, Small Interfering

Identifiers

PMID21535316
PMCPMC11159092
OpenAlexW2147931669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.